Delivery Order SPE2DB25D3005-SPE2DB25FQFLP
Award Date
5/23/25
Potential Completion Date
5/27/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.07 firm fixed-price delivery order is for the supply of loteprednol etabonate 0.5% eye drops, a medication used for the treatment of various eye conditions. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a $1,776.60 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL containers. The contract is a Firm Fixed Price agreement with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
This federal contract award, with the ID SPE2DB20D1109|SPE2DB25FN47E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loteprednol Etabonate 0.2% eye drops, a pharmaceutical product, with a ceiling value of $1,107.62 and a completion date of February 3, 2025. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,672.09, is for the delivery of Loteprednol Etabonate 0.5% eye drops. The contract is a firm fixed-price delivery order with a completion date of December 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,845.34 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% eyedrops (10 ml). This is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of loteprednol etabonate 0.5% eye drops, in 5 ml quantities, to the Defense Logistics Agency (DLA). The $2,143.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 1, 2023, with an ultimate completion date of March 2, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of a pharmaceutical product, loteprednol etabonate 0.2% eye drops, with a ceiling value of $3,286.90 and a period of performance through April 5, 2024. The contract is a firm fixed price delivery order with no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,405.28 firm-fixed-price delivery order is for the supply of 4558884048 - Loteprednol Etabonate 0.5% Eye Drops in 5 mL containers. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL10X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of loteprednol etabonate 0.2% eye drops, a pharmaceutical product, with an ultimate completion date of December 31, 2024 and a ceiling value of $1,122.87. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not...